Colorectal Neoplasms  >>  linsitinib (ASP7487)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
linsitinib (ASP7487) / Sling Therap
NCT00514306: Study of Intermittent OSI-906 Dosing

Completed
1
79
US, Europe
OSI-906
Astellas Pharma Inc
Advanced Solid Tumors
09/10
09/10
NCT00514007: Study of Continuous OSI-906 Dosing

Completed
1
95
US, Europe
OSI-906
Astellas Pharma Inc
Advanced Solid Tumors
03/12
03/12
NCT01016860: OSI-906 and Irinotecan in Patients With Advanced Cancer

Terminated
1
16
US
OSI-906, Linsitinib, irinotecan, Camptosar
University of Colorado, Denver
Colorectal Cancer
04/13
04/13

Download Options